Subscribe to Optik:

Prisme Optical Group Welcomes a New US National Sales Manager

Prisme Optical Group has announced the appointment of Guillaume Pottecher as the new United States, National Sales Manager. He will report to Carole Menard, Vice President of Sales.

Guillaume brings 15 years of industry knowledge and established relationships and extensive experience in the high end segment of the optical industry. Guillaume introduced the brand Tag Heuer to the US market and has worked with De Rigo. Guillaume will be responsible for: sales, networking, territory development and training, recruiting qualified representatives, business relations for groups and important key accounts in the US.

Prisme Optical Group is a North American leader in the distribution of high end frames including brands, such as Beausoleil, Oliver Goldsmith Spectacle, Xavier Garcia Barcelona and Tartine & Chocolat.

www.prismeoptical.com

Screen shot 2015-02-17 at 4.41.21 PM

Highlights from Optik Magazine

The Kick off CE course is about Social media
Discover the A+ Method (Assess, Acknowledge, Adjust) to build trust,
Specsavers marks milestone with the reopening and expansion of its
A new study shows B vitamins and choline may protect
Discover the Blackfin Cobalt 1083 titanium frame: ultra-light, hypoallergenic, Made
Costa Sunglasses has expanded its lifestyle collection with Trades and
From Stadium to Street: Three Frames That Embody Patrick Mahomes
Crafted in stainless steel with hand-painted accents, Chiavari’s silhouette is
Discover the latest kids’ and teens’ eyewear trends—frames, lens tech,
Discover the A+ Method (Assess, Acknowledge, Adjust) to build trust,
An enhanced Myopia Tool Kit is now available from the
Learn how eyewearprofessionals Kim Manias and Christine Zeggil are shaping
Three ways frame quality vs. quantity can be the difference
A new study shows B vitamins and choline may protect
KAIST researchers may have unlocked retina regeneration by blocking the
A study in ACS Nano shows that gold nanoparticles may
Fighting Blindness Canada is sharing clinical trial updates on two
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.